Abri Science
We're an advanced materials company working to improve human health via the microencapsulation of enzymes.
We're an advanced materials company working to improve human health via the microencapsulation of enzymes.
Abri Science is a Baltimore-based startup founded in 2019 that focuses on advancing human health through the microencapsulation of enzymes. Their mission is underlined by their slogan, "We're an advanced materials company working to improve human health via the microencapsulation of enzymes." By encapsulating enzymes and catalysts within a semi-permeable membrane, they aim to shield them from harsh environments, thus enhancing their efficacy. Specializing in the Health Care industry, the company has received a notable $225.00K grant investment as of 20 September 2019. Notably, the investment was made by the National Institute of Diabetes and Digestive and Kidney Diseases, showcasing recognition and support from a prominent entity in the healthcare field. Abri Science's commitment to innovation and health improvement makes it an intriguing prospect for potential investors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $225.00K | 1 | National Institute of Diabetes and Digestive and Kidney Diseases | 20 Sep 2019 |
No recent news or press coverage available for Abri Science.
We care about your data, and we'd love to use cookies make your experience better.